NO996573D0 - Spesielle diarylimidazol-derivater, en ny klasse av NPY- spesifikke ligander - Google Patents
Spesielle diarylimidazol-derivater, en ny klasse av NPY- spesifikke liganderInfo
- Publication number
- NO996573D0 NO996573D0 NO996573A NO996573A NO996573D0 NO 996573 D0 NO996573 D0 NO 996573D0 NO 996573 A NO996573 A NO 996573A NO 996573 A NO996573 A NO 996573A NO 996573 D0 NO996573 D0 NO 996573D0
- Authority
- NO
- Norway
- Prior art keywords
- npy
- special
- new class
- specific ligands
- diarylimidazole derivatives
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5171197P | 1997-07-03 | 1997-07-03 | |
| PCT/US1998/013861 WO1999001128A1 (en) | 1997-07-03 | 1998-07-02 | Certain diarylimidazole derivatives; a new class of npy specific ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO996573D0 true NO996573D0 (no) | 1999-12-30 |
| NO996573L NO996573L (no) | 2000-02-23 |
Family
ID=21972909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO996573A NO996573L (no) | 1997-07-03 | 1999-12-30 | Spesielle diarylimidazol-derivater, en ny klasse av NPY- spesifikke ligander |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6121260A (no) |
| EP (1) | EP0996443A1 (no) |
| JP (1) | JP2002515400A (no) |
| KR (1) | KR20010020610A (no) |
| CN (1) | CN1265033A (no) |
| AU (1) | AU744297B2 (no) |
| BR (1) | BR9810651A (no) |
| CA (1) | CA2294898A1 (no) |
| HU (1) | HUP0003934A3 (no) |
| IL (1) | IL133731A0 (no) |
| NO (1) | NO996573L (no) |
| PL (1) | PL337887A1 (no) |
| WO (1) | WO1999001128A1 (no) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6590106B2 (en) * | 1997-05-09 | 2003-07-08 | Pharm-Eco Laboratories, Inc. | Amino acid derivatives and methods of making the same |
| HUP0003934A3 (en) * | 1997-07-03 | 2002-01-28 | Pfizer | A part of diaryl imidazole derivatives, pharmaceutical composit |
| US6340683B1 (en) | 1999-04-22 | 2002-01-22 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (triazines) |
| EP1816127A1 (en) | 1999-04-22 | 2007-08-08 | H. Lundbeck A/S | Triazine derivatives for use as selective npy (y5) antagonists |
| US6989379B1 (en) | 1999-04-22 | 2006-01-24 | H. Lundbick A/S | Selective NPY (Y5) antagonists |
| AU2935200A (en) * | 1999-04-30 | 2000-11-17 | Pfizer Products Inc. | Compounds for the treatment of obesity |
| AR024077A1 (es) | 1999-05-25 | 2002-09-04 | Smithkline Beecham Corp | Compuestos antibacterianos |
| ES2250126T3 (es) * | 1999-06-30 | 2006-04-16 | H. Lundbeck A/S | Antagonistas selectivos del npy(y5). |
| US7273880B2 (en) | 1999-06-30 | 2007-09-25 | H. Lunbeck A/S | Selective NPY (Y5) antagonists |
| EP1070708B1 (en) | 1999-07-21 | 2004-01-14 | F. Hoffmann-La Roche Ag | Triazole derivatives |
| DE60022386T2 (de) | 1999-12-16 | 2006-06-22 | Schering Corp. | Substituierte imidazole als neuropeptide y y5 rezeptor antagonisten |
| ES2236178T3 (es) | 2000-02-22 | 2005-07-16 | Banyu Pharmaceutical Co., Ltd. | Nuevos compuestos de imidazolina. |
| WO2002083111A2 (en) | 2001-04-16 | 2002-10-24 | Tanabe Seiyaku Co., Ltd. | Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| KR20040004705A (ko) * | 2001-06-08 | 2004-01-13 | 시토비아 인크. | 카스파제의 활성제 및 아폽토시스의 유도제로서의 치환된3-아릴-5-아릴-[1,2,4]-옥사디아졸과 유사체 및 이의 용도 |
| US7124183B2 (en) | 2001-09-26 | 2006-10-17 | Bell Security Solutions Inc. | Method and apparatus for secure distributed managed network information services with redundancy |
| AU2003224335A1 (en) * | 2002-05-15 | 2003-12-02 | Smithkline Beecham Corporation | Benzoxazine and benzoxazinone substituted triazoles |
| AU2003257329C1 (en) | 2002-08-19 | 2010-07-22 | Lorus Therapeutics Inc. | 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| US6949564B2 (en) | 2002-12-18 | 2005-09-27 | Pfizer Inc. | NPY-5 antagonists |
| US6958347B2 (en) | 2002-12-18 | 2005-10-25 | Pfizer Inc. | Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists |
| EP1581213A4 (en) * | 2002-12-18 | 2008-11-19 | Cytovia Inc | 3,5-DISUBSTITUTED 1,2,4-OXADIAZOLE AND ANALOGUE TO ACTIVATE CASPASE AND INTRODUCTION OF APOPTOSIS AND THEIR USE |
| US8969372B2 (en) | 2003-11-14 | 2015-03-03 | Aptose Boisciences Inc. | Aryl imidazoles and their use as anti-cancer agents |
| CN1964949B (zh) * | 2004-06-10 | 2010-06-23 | 四国化成工业株式会社 | 在焊接过程中用于铜表面上的苯基萘基咪唑 |
| JP4694251B2 (ja) * | 2004-06-10 | 2011-06-08 | 四国化成工業株式会社 | 無鉛半田付け用の銅または銅合金の表面処理剤及びその利用 |
| US8183386B2 (en) | 2004-06-10 | 2012-05-22 | Shikoku Chemicals Corporation | Phenylnaphthylimidazole compound and usage of the same |
| AU2006250809B2 (en) | 2005-05-25 | 2011-05-12 | Lorus Therapeutics Inc. | 2-indolyl imidazo(4,5-D)phenanthroline derivatives and their use in the treatment of cancer |
| PE20070335A1 (es) | 2005-08-30 | 2007-04-21 | Novartis Ag | Benzimidazoles sustituidos y metodos para su preparacion |
| US9447049B2 (en) * | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
| AU2009330686B2 (en) | 2008-06-16 | 2014-07-03 | The Ohio State University Research Foundation | Compounds for the treatment of cancer |
| JP5361316B2 (ja) * | 2008-10-02 | 2013-12-04 | 株式会社タムラ製作所 | 表面処理剤、プリント回路基板およびその製造方法 |
| JP5615227B2 (ja) | 2011-05-23 | 2014-10-29 | 四国化成工業株式会社 | 銅または銅合金の表面処理剤及びその利用 |
| JP5858884B2 (ja) * | 2012-08-16 | 2016-02-10 | 四国化成工業株式会社 | チオフェン環を有するイミダゾール化合物 |
| JP5892605B2 (ja) * | 2012-08-17 | 2016-03-23 | 四国化成工業株式会社 | ４−（２−チエニル）イミダゾール化合物 |
| WO2014153464A2 (en) | 2013-03-20 | 2014-09-25 | Lorus Therapeutics Inc. | 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| ES2775579T3 (es) | 2013-10-04 | 2020-07-27 | Aptose Biosciences Inc | Composiciones para el tratamiento del cáncer |
| ES2815374T3 (es) | 2014-05-06 | 2021-03-29 | Oncternal Therapeutics Inc | Compuestos para el tratamiento del cáncer |
| CN104974095B (zh) * | 2015-06-30 | 2017-09-15 | 浙江大学 | 2,4,5‑多取代咪唑类化合物及制备方法 |
| CN111417395A (zh) | 2017-10-30 | 2020-07-14 | 艾普托斯生物科学公司 | 用于治疗癌症的芳基咪唑 |
| WO2022236253A1 (en) * | 2021-05-03 | 2022-11-10 | Nuvation Bio Inc. | Heterocyclic compounds as kinase inhibitors |
| EP4173485A1 (en) * | 2021-10-27 | 2023-05-03 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Protein aggregation inhibiting compounds for plant disease control |
| CN115043779B (zh) * | 2022-06-14 | 2024-06-25 | 广东金柏化学有限公司 | 一种2,4-二苯基咪唑化合物及其制备方法与应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE297816C (no) * | ||||
| US3297710A (en) * | 1963-04-09 | 1967-01-10 | Du Pont | Oxoarylidene-imidazoles |
| US3657441A (en) * | 1970-07-30 | 1972-04-18 | Merck & Co Inc | Method of inhibiting the formation of phenylethanolamine n-methyl transferase with imidazoles |
| US3707475A (en) | 1970-11-16 | 1972-12-26 | Pfizer | Antiinflammatory imidazoles |
| US4134983A (en) * | 1975-03-03 | 1979-01-16 | Merck & Co., Inc. | 3-amino-2-or-propoxyaryl substituted imidazoles |
| US4853383A (en) * | 1975-03-03 | 1989-08-01 | Merck & Co., Inc. | β-blocking substituted imidazoles |
| SU1051076A1 (ru) * | 1982-04-09 | 1983-10-30 | Алтайский политехнический институт | Способ получени производных имидазола |
| IT1206498B (it) | 1983-07-18 | 1989-04-27 | Angeli Inst Spa | Derivati amidinici del4-fenilmidazolo 2-sostituto processi per la loro preparazione e loro uso farmaceutico. |
| DE3411997A1 (de) * | 1984-03-31 | 1985-10-17 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue redox-indikatoren |
| IN165525B (no) * | 1984-07-23 | 1989-11-04 | Shinetsu Chemical Co | |
| PT80975B (pt) * | 1984-08-17 | 1987-11-11 | Shinetsu Chemical Co | Processo para a preparacao de um polimero de vinilo |
| IL83467A0 (en) * | 1986-08-15 | 1988-01-31 | Fujisawa Pharmaceutical Co | Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same |
| JP2630432B2 (ja) * | 1987-08-24 | 1997-07-16 | コニカ株式会社 | 新規なシアンカプラーを含有するハロゲン化銀カラー写真感光材料 |
| JP2700475B2 (ja) * | 1988-07-30 | 1998-01-21 | コニカ株式会社 | 非線形光学材料および非線形光学素子 |
| DE3835195A1 (de) * | 1988-10-15 | 1990-04-19 | Basf Ag | Verfahren zur herstellung von p-nitrophenyl-imidazolen |
| AU621245B2 (en) * | 1989-10-17 | 1992-03-05 | Boehringer Mannheim Gmbh | Hydrolase substrates, a process for the preparation thereof and agents containing them |
| ES2058651T3 (es) * | 1990-03-30 | 1994-11-01 | Heumann Pharma Gmbh & Co | Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy. |
| US5296609A (en) * | 1993-04-09 | 1994-03-22 | Syntex Pharmaceuticals, Ltd. | Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives |
| TW270944B (no) * | 1993-05-10 | 1996-02-21 | Shikoku Kakoki Co Ltd | |
| US5620999A (en) * | 1994-07-28 | 1997-04-15 | Weier; Richard M. | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation |
| AU7692996A (en) * | 1995-12-01 | 1997-06-27 | Ciba-Geigy Ag | Receptor antagonists |
| HUP0003934A3 (en) * | 1997-07-03 | 2002-01-28 | Pfizer | A part of diaryl imidazole derivatives, pharmaceutical composit |
-
1998
- 1998-07-02 HU HU0003934A patent/HUP0003934A3/hu unknown
- 1998-07-02 BR BR9810651-1A patent/BR9810651A/pt not_active IP Right Cessation
- 1998-07-02 JP JP2000500894A patent/JP2002515400A/ja active Pending
- 1998-07-02 CN CN98807669A patent/CN1265033A/zh active Pending
- 1998-07-02 CA CA002294898A patent/CA2294898A1/en not_active Abandoned
- 1998-07-02 EP EP98933135A patent/EP0996443A1/en not_active Withdrawn
- 1998-07-02 PL PL98337887A patent/PL337887A1/xx not_active Application Discontinuation
- 1998-07-02 US US09/109,558 patent/US6121260A/en not_active Expired - Fee Related
- 1998-07-02 IL IL13373198A patent/IL133731A0/xx unknown
- 1998-07-02 AU AU82868/98A patent/AU744297B2/en not_active Ceased
- 1998-07-02 WO PCT/US1998/013861 patent/WO1999001128A1/en not_active Ceased
- 1998-07-02 KR KR1019997012624A patent/KR20010020610A/ko not_active Ceased
-
1999
- 1999-12-30 NO NO996573A patent/NO996573L/no not_active Application Discontinuation
-
2000
- 2000-03-10 US US09/523,328 patent/US6515133B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU8286898A (en) | 1999-01-25 |
| WO1999001128A1 (en) | 1999-01-14 |
| IL133731A0 (en) | 2001-04-30 |
| AU744297B2 (en) | 2002-02-21 |
| CA2294898A1 (en) | 1999-01-14 |
| HUP0003934A2 (hu) | 2001-11-28 |
| BR9810651A (pt) | 2000-10-03 |
| CN1265033A (zh) | 2000-08-30 |
| NO996573L (no) | 2000-02-23 |
| PL337887A1 (en) | 2000-09-11 |
| HUP0003934A3 (en) | 2002-01-28 |
| JP2002515400A (ja) | 2002-05-28 |
| US6515133B1 (en) | 2003-02-04 |
| KR20010020610A (ko) | 2001-03-15 |
| US6121260A (en) | 2000-09-19 |
| EP0996443A1 (en) | 2000-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO996573D0 (no) | Spesielle diarylimidazol-derivater, en ny klasse av NPY- spesifikke ligander | |
| NO972091D0 (no) | Bestemte substituerte benzylaminderivater; en ny klasse nouropeptid-yl-spesifikke ligander | |
| DE69907964D1 (de) | 1,2-annelierte chinolinderivate | |
| NO971423D0 (no) | Bestemte aminometyl-fenylimidazol-derivater; en ny klasse spesifikke dopaminreseptor-undertype-ligander | |
| DK0966477T3 (da) | 3'-N-oxid, 3'-N-dimethylamin, 9-oxim-erythromycin A-derivater | |
| IS1998B (is) | 4'' -setnar - 9 - deoxó - 9 - aza - 9a - hómóerýþrómýsín A afleiður | |
| CY2007024I2 (el) | Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων | |
| PT1000048E (pt) | Derivados substituidos do 1,2,3,4-tetrahidronaftaleno | |
| DK0918761T3 (da) | Visse amido- og aminosubstituerede benzylaminderivater, en ny klasse af neuropeptid Y1-specifikke ligander | |
| DE69715847D1 (de) | Halogensubstituierte Carbamatderivate von 2-Phenyl-1,2-ethandiol | |
| DK0864582T3 (da) | Hypolidemiske 1,4-benzothiazepin-1,1-dioxider | |
| FI974139A0 (fi) | Foerfarande foer modifiering av cellulosa | |
| DE69932408D1 (de) | Radiale strömungsmaschine | |
| FI952424L (fi) | 11,21-bisfenyyli-19-norpregaanijohdannaisia | |
| DE69800225D1 (de) | Kapselmaschine | |
| PT921125E (pt) | Derivados de 1,38-triaza-espiro 4,5 decan-4-ona | |
| TR199800988A3 (tr) | 5' Deoksi-Sitidin türevleri. | |
| FR2730007B1 (fr) | Machine a ecoulement radial | |
| EE9900391A (et) | Uus protsess | |
| ITBO970535A0 (it) | Macchina impacchettatrice. | |
| FI973644L (fi) | Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi | |
| NO995005D0 (no) | En ny fremgangsmåte | |
| FI955933L (fi) | Abeo-ergoliinijohdannaiset 5HT1A-ligandeina | |
| NO319779B1 (no) | Arbeidsantrekk, saerlig skogsarbeiderantrekk, bestaende av en bukse og av en jakke. | |
| FI972885A0 (fi) | Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |